SEC Form 4 · accession 0001104659-17-046277
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John T Cavan
Officer — Chief Financial Officer
Period of report
Jul 20, 2017
Accepted (ET)
Jul 21, 2017 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583771
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $0.58 | Jul 20, 2017 | A | 15,000 | A | — | Jul 20, 2027 | Common Stock | 15,000 | 133,688 | D |
Explanation of responses
- F1Options vest in three installments as follows: 5,000 vest on each of July 20, 2018, 2019 and 2020.